Advertisement

Topics

BIOLASE Announces Inducement Grant under NASDAQ Listing Rule 5635(c)(4)

06:00 EDT 14 Mar 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
BIOLASE, Inc. (NASDAQ:BIOL), the global leader in dental lasers, today announced that on March 13, 2017, James D. Surek, the Company’s newly hired Vice President of Sales for the Americas, received options to purchase 400,000 ...

Other Sources for this Article

BIOLASE
Harold C. Flynn, Jr.
President, CEO
hflynn@biolase.com
949-226-8100
or
DresnerAllenCaron
Michael Mason (Investors)
mmason@dresnerallencaron.com
212-691-8087
or
Rene Caron (Investors)
rcaron@dresnerallencaron.com
or
Len Hall (Media)
lhall@dresnerallencaron.com
949-474-4300

NEXT ARTICLE

More From BioPortfolio on "BIOLASE Announces Inducement Grant under NASDAQ Listing Rule 5635(c)(4)"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Dentistry
Dentistry is the study, management and treatment of diseases and conditions affecting the mouth, jaw, teeth and their supporting tissues (Oxford Medical Dictionary) The work of a dentist ranges from regular patient check-up to orthodontics and surgery....

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...